HealthEquity Q2 Results: EPS beats estimate, revenue up 7.6%

1 min read | Published on 27 Aug 2026, 06:10 PM |Updated on 27 Aug 2026, 06:10 PM

Reviewed by

Anirudha BScanX News Team

Add as a preferred
source on Google

Key Highlights

Adjusted EPS of $1.24 beat the $1.19 estimate by 4.2%
Revenue rose 7.64% YoY to $350.732 million
Sales surpassed the $349.248 million consensus estimate
EPS growth of 14.81% outpaced revenue growth

*this image is generated using AI for illustrative purposes only.

HealthEquity (NASDAQ: HQY) delivered a second-quarter performance that exceeded analyst expectations on both earnings and revenue fronts. The health savings account provider reported adjusted earnings per share of $1.24, surpassing the consensus estimate of $1.19.

The top-line growth was equally robust. Quarterly sales reached $350.732 million, beating the analyst consensus of $349.248 million. This represents a year-over-year increase of 7.64% from $325.835 million in the same period last year.

Financial Performance

The company’s ability to grow both revenue and profitability simultaneously suggests operational leverage in its current business model. While revenue grew by 7.64%, adjusted EPS expanded by a more significant 14.81% compared to $1.08 per share in the prior-year quarter.

Metric	Current Quarter	Prior Year Quarter	Change
Adjusted EPS	$1.24	$1.08	+14.81%
Revenue	$350.732 million	$325.835 million	+7.64%

What the Numbers Show

The divergence between the revenue growth rate and the earnings growth rate is notable. With EPS rising nearly twice as fast as revenue (14.81% vs 7.64%), the data indicates that cost efficiencies or margin expansion played a significant role in driving profitability, rather than volume growth alone. This operational efficiency allowed the company to not only beat estimates but also significantly outpace its own prior-year profit trajectory.

Will HealthEquity's demonstrated operational leverage and margin expansion be sustainable in upcoming quarters as revenue growth normalizes?

How might the current competitive landscape in the HSA market impact HealthEquity's ability to maintain its 7.64% revenue growth trajectory?

Are there specific cost-cutting measures or efficiency initiatives driving the disproportionate EPS growth that could face diminishing returns?

HealthEquity Q2 Results: Earnings release set for August 27

1 min read | Published on 04 Aug 2026, 01:43 AM |Updated on 04 Aug 2026, 01:43 AM

Reviewed by

Shriram SScanX News Team

Add as a preferred
source on Google

Key Highlights

HealthEquity Inc. will report Q2 FY27 earnings on August 27, 2026, followed by an earnings call. Management will also present at Wells Fargo, Baird, and Deutsche Bank healthcare conferences in September 2026.

*this image is generated using AI for illustrative purposes only.

HealthEquity Inc., the largest independent health savings account (HSA) custodian by account volume, announced on August 3, 2026, that it will release its financial results for the second quarter of fiscal 2027 on Thursday, August 27, 2026. The earnings release is scheduled for before the opening of regular stock market trading. Investors and analysts should note this date as the primary trigger for potential volatility in the company’s shares listed on NASDAQ under the ticker HQY.

Following the publication of the results, HealthEquity management will host a conference call at 8:30 a.m. Eastern Time (6:30 a.m. Mountain Time) to review the quarter’s performance. The call will be accessible via dial-in and webcast. A replay of the conference call will be available on the company’s investor relations website at ir.healthequity.com.

Conference Call Details

Detail	Information
Date	August 27, 2026
Time	8:30 a.m. Eastern Time
Dial-In (US/Canada)	1-833-630-1956
Dial-In (International)	1-412-317-1837
Conference ID	HealthEquity
Webcast	ir.healthequity.com

In addition to the earnings call, HealthEquity management plans to present and meet with investors at several upcoming industry conferences. These engagements provide further opportunities for stakeholders to discuss the company’s strategy and operational updates beyond the quarterly financials.

Upcoming Investor Conferences

Conference	Date	Time (ET)	Location
21st Annual Wells Fargo Healthcare Conference	September 9, 2026	9:30 a.m.	Encore Boston
2026 Baird Global Healthcare Conference	September 15, 2026	2:35 p.m.	Intercontinental Barclays Hotel
2026 Deutsche Bank Healthcare Summit	September 16, 2026	1x1 meetings only	Deutsche Bank Center – Columbus Circle, New York

HealthEquity and its subsidiaries administer HSAs and various other consumer-directed benefits for over 17 million accounts. The company works with employers, benefits advisors, and health and retirement plan providers. The press release included standard forward-looking statements regarding risks related to custodial asset placement, competition, regulatory changes, and cybersecurity, as detailed in the company’s Annual Report on Form 10-K for the fiscal year ended January 31, 2026.

How might HealthEquity's Q2 2027 revenue growth trajectory compare to its peers in the face of increasing competition from major banks and fintech firms entering the HSA space?

What specific strategies is HealthEquity employing to mitigate the regulatory risks associated with potential changes to HSA tax advantages or eligibility criteria in upcoming legislative sessions?

To what extent will the company's expansion into broader consumer-directed benefits beyond traditional HSAs contribute to margin improvement in the second half of fiscal 2027?